Related Experiment Videos
Transcriptional repression mediated by the p53 tumour suppressor
1Department of Medical Biophysics, Ontario Cancer Institute, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9.
Cell Death and Differentiation
|April 30, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Feeding difficulties in childhood: A narrative review and proposal for an interdisciplinary approach.
Revista de gastroenterologia de Mexico (English)·2026
Building better memories pilot study: Memory rehabilitation for consumers of electroconvulsive therapy.
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2025
Measurements of Pion and Muon Nuclear Capture at Rest on Argon in the LArIAT Experiment.
Physical review letters·2025
Lipidomic Analysis Reveals Drug-Induced Lipoxins in Glaucoma Treatment.
bioRxiv : the preprint server for biology·2025
Gut microbiome metagenomic sequences of honey bees (Apis mellifera) exposed to crops.
Microbiology resource announcements·2025
Wastewater monitoring - passive sampling for the detection of SARS-CoV-2 and antibiotic resistance genes in wastewater.
The Science of the total environment·2024
AURKB-mediated phosphorylation of metabolic enzyme CD73 drives immune suppression and renal cell carcinoma progression.
Cell death and differentiation·2026
Astrocytic LCN2 mediates pathological crosstalk with neurons to promote neuronal loss in sepsis-associated encephalopathy.
Cell death and differentiation·2026
A targetable ALDH3A2-NRF2 axis mediates KEAP1-mutant tumour development via ferroptosis inhibition.
Cell death and differentiation·2026
PIDDosome deficiency impairs bone remodeling by increasing osteoclast ploidy and function.
Cell death and differentiation·2026
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance.
Cell death and differentiation·2026
Assessment of Natural Killer Cell Serial Degranulation.
Current protocols·2026
Stimuli-responsive nanocarriers for precision cation channel therapy.
Chemical communications (Cambridge, England)·2026
Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer's disease neuropathology: Preliminary observations.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026